Ironwood Pharmaceuticals IRWD Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $104.45M+297% | $26.29M-7.9% | $28.55M+462% | -$7.89M+75.6% | -$32.34M-3,775% | ||
| $1.85M-1.9% | $1.88M-1.3% | $1.91M-1.7% | $1.94M-2.0% | $1.98M-1.7% | ||
| $15.61M-9.5% | $17.25M-4.1% | $17.99M-20.8% | $22.71M-15.1% | $26.76M-10.4% | ||
| $61.07M+43.5% | $42.55M-49.1% | $83.65M+31.6% | $63.56M+1.4% | $62.71M-7.9% | ||
| $66.07M+288% | -$35.15M— | —— | —— | —— | ||
| -$8.03M-223% | $6.52M+750% | $767K+108% | -$9.93M-619% | $1.91M+109% | ||
| -$6.77M-1,745% | -$367K+76.3% | -$1.55M— | —— | —— | ||
| $3.7M-9.9% | $4.11M+123% | -$17.57M-31.6% | -$13.35M-18.8% | -$11.24M-9.6% | ||
| $1.72M+2.1% | $1.69M+2.0% | $1.66M+2.0% | $1.62M+2.1% | $1.59M+2.0% | ||
| -$2.42M-2.1% | -$2.37M-2.2% | -$2.32M-2.2% | -$2.27M-2.1% | -$2.23M-2.3% | ||
| —— | —— | —— | —— | $78.52M-24.2% | ||
| —— | $35K0.0% | $35K-28.6% | $49K-53.3% | $105K-26.1% | ||
| —— | -$35K0.0% | -$35K+28.6% | -$49K+53.3% | -$105K+26.1% | ||
| —— | $216K-27.3% | $297K0.0% | $297K-69.0% | $958K-91.3% | ||
| —— | $216K+101% | -$14.79M+64.7% | -$41.95M+54.1% | -$91.41M+14.5% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $30.33M-1.8% | $30.89M-1.8% | $31.45M-1.7% | $32.01M-1.7% | ||
| —— | $3.54M-25.6% | $4.76M-20.4% | $5.98M-16.9% | $7.19M-14.5% | ||
| $1.85M-1.9% | $1.88M-1.3% | $1.91M-1.7% | $1.94M-2.0% | $1.98M-1.7% | ||
| -$4.15M-1.2% | -$4.11M+37.4% | -$6.56M— | —— | —— | ||
| -$2.42M-2.1% | -$2.37M-2.2% | -$2.32M-2.2% | -$2.27M-2.1% | -$2.23M-2.3% | ||
| $3.7M-9.9% | $4.11M+123% | -$17.57M-31.6% | -$13.35M-18.8% | -$11.24M-9.6% | ||
| -$427K+4.5% | -$447K— | —— | —— | —— | ||
| -$6.77M-1,745% | -$367K+76.3% | -$1.55M— | —— | —— | ||
| $1.72M+2.1% | $1.69M+2.0% | $1.66M+2.0% | $1.62M+2.1% | $1.59M+2.0% | ||
| $1.67M+0.2% | $1.67M+0.2% | $1.67M+4.3% | $1.6M-7.7% | $1.73M-9.1% | ||
| —— | $216K-27.3% | $297K0.0% | $297K-69.0% | $958K-91.3% | ||
| —— | $3.54M-25.6% | $4.76M-20.4% | $5.98M-16.9% | $7.19M-14.5% | ||
| —— | —— | —— | —— | $78.41M-24.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Ironwood Pharmaceuticals generate?
- Ironwood Pharmaceuticals (IRWD) generated $147.2M in operating cash flow over the trailing twelve months.
- Where does Ironwood Pharmaceuticals's cash flow data come from?
- Every line is extracted from Ironwood Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
